Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 May;47(5):641–647. doi: 10.1038/bjc.1983.102

Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice.

N Brünner, M Spang-Thomsen, L Vindeløv, A Nielsen
PMCID: PMC2011400  PMID: 6849802

Abstract

The effect of 17 beta-oestradiol on a "receptor positive" and on a "receptor negative" human breast carcinoma grown in nude mice was studied. Experimental growth data were used to determine the effect on tumour growth. Flow cytometric DNA analysis (FCM) performed on tumour tissue obtained by sequential fine-needle aspirations was used to estimate the effect on the cell cycle. In the receptor-positive breast carcinoma, oestradiol induced complete tumour regression and characteristic cell cycle changes. In the receptor-negative breast carcinoma, no changes in tumour growth and cell cycle distribution could be demonstrated following the treatment. The results indicate that the oestradiol-induced cell kill could be explained to some extent by the induction of polyploid cells, which eventually die. Since the cell cycle changes monitored by FCM in the receptor-positive breast carcinoma appeared prior to any reduction in the tumour size, the results suggest that FCM may prove a valuable method in the early detection of tumour response to hormone treatment in human breast cancer.

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlogie B., Drewinko B., Johnston D. A., Freireich E. J. The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line. Cancer Res. 1976 Jun;36(6):1975–1979. [PubMed] [Google Scholar]
  2. Brennan M. J., Donegan W. L., Appleby D. E. The variability of estrogen receptors in metastatic breast cancer. Am J Surg. 1979 Feb;137(2):260–262. doi: 10.1016/0002-9610(79)90159-4. [DOI] [PubMed] [Google Scholar]
  3. Brünner N., Visfeldt J. Histologic changes following oestradiol treatment of a hormone-responsive human breast carcinoma grown in nude mice. Acta Pathol Microbiol Immunol Scand A. 1982 Sep;90(5):355–362. doi: 10.1111/j.1699-0463.1982.tb00106_90a.x. [DOI] [PubMed] [Google Scholar]
  4. Butler W. B., Kelsey W. H., Goran N. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res. 1981 Jan;41(1):82–88. [PubMed] [Google Scholar]
  5. Dao T. L., Sinha D. K., Nemoto T., Patel J. Effect of estrogen and progesterone on cellular replication of human breast tumors. Cancer Res. 1982 Jan;42(1):359–362. [PubMed] [Google Scholar]
  6. Emment Y., Collins W. P. Radioimmunoassay of oestrone and oestradiol in human plasma. Acta Endocrinol (Copenh) 1972 Mar;69(3):567–582. doi: 10.1530/acta.0.0690567. [DOI] [PubMed] [Google Scholar]
  7. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976 Dec;36(12):4595–4601. [PubMed] [Google Scholar]
  8. Nordenskjöld B., Löwhagen T., Westerberg H., Zajicek J. 3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy. Acta Cytol. 1976 Mar-Apr;20(2):137–143. [PubMed] [Google Scholar]
  9. Spang-Thomsen M., Nielsen A., Visfeldt J. Growth curves of three human malignant tumors transplanted to nude mice. Exp Cell Biol. 1980;48(2):138–154. doi: 10.1159/000162982. [DOI] [PubMed] [Google Scholar]
  10. Spang-Thomsen M., Visfeldt J., Nielsen A. Effect of single-dose X irradiation on the growth curves of a human malignant melanoma transplanted into nude mice. Radiat Res. 1981 Jan;85(1):184–195. [PubMed] [Google Scholar]
  11. Tobey R. A., Deaven L. L., Oka M. S. Kinetic response of cultured Chinese hamster cells to treatment with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl. J Natl Cancer Inst. 1978 May;60(5):1147–1153. doi: 10.1093/jnci/60.5.1147. [DOI] [PubMed] [Google Scholar]
  12. Tropé C., Aspegren K., Kullander S., Astedt B. Heterogeneous response of disseminated human ovarian cancers to cytostatics in vitro. Acta Obstet Gynecol Scand. 1979;58(6):543–546. doi: 10.3109/00016347909154616. [DOI] [PubMed] [Google Scholar]
  13. Vindeløv L. L., Hansen H. H., Gersel A., Hirsch F. R., Nissen N. I. Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis. Cancer Res. 1982 Jun;42(6):2499–2505. [PubMed] [Google Scholar]
  14. Webster D. J., Bronn D. G., Minton J. P. Estrogen receptor levels in multiple biopsies from patients with breast cancer. Am J Surg. 1978 Sep;136(3):337–338. doi: 10.1016/0002-9610(78)90289-1. [DOI] [PubMed] [Google Scholar]
  15. Weichselbaum R. R., Hellman S., Piro A. J., Nove J. J., Little J. B. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1978 Aug;38(8):2339–2342. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES